Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib treatment study in primary hypertrophic osteoarthropathy
ChiCTR-OPB-15006424Phase 4Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of etoricoxib in Pachydermoperiostosis (PDP), sponsored by Shanghai Sixth People's Hospital. Primary endpoints: Tibiofibula X-ray, Markers of bone turnover and 2 more. Planned start Jun 2015; status: not yet recruiting.
02
Drugs
etoricoxib
03
Conditions
Pachydermoperiostosis (PDP)
Beyond the preview
Go deeper on ChiCTR-OPB-15006424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPB-15006424.